grace targeted therapies lung cancer 2021 options after progression on alectinib?
Published 2 years ago • 35 plays • Length 4:06Download video MP4
Download video MP3
Similar videos
-
2:39
grace targeted therapies lung cancer 2021 - return to alectinib -progression on lorlatinib in alk
-
21:58
grace targeted therapies lung cancer 2021 - alk therapies-which one comes first, how do we sequence?
-
1:39
grace targeted therapies lung cancer 2021 - treatment after crizotinib in ros1 lung cancer
-
3:35
grace targeted therapies lung cancer 2021 - recommended treatment for an alk variant 1 patient
-
20:32
grace targeted therapies lung cancer 2021 - ros current therapies, emerging treatment options
-
2:01
grace targeted therapies lung cancer 2021 - data learned from ensartinib for ros1 in clinical trial?
-
2:08
grace targeted therapies lung cancer 2021 - approved therapy for a cdkn2a secondary mutation?
-
4:17
grace targeted therapies lung cancer 2021 - utility & benefit 3rd generation tki after progression
-
16:03
grace targeted therapies lung cancer 2021 -the role of chemotherapy in driver positive patients
-
2:43
grace targeted therapies in lung cancer 2021 - opinions on various costs and treatment options
-
21:33
optimal ngs platforms, how to interpret - grace targeted therapies in lung cancer patient forum 2021
-
14:33
grace targeted therapies lung cancer 2021 - targeted therapies in oligo-metastatic disease
-
22:44
grace targeted therapies lung cancer 2021 - new therapies: ntrk, ret and her2
-
1:58
grace targeted therapies lung cancer 2021 - other data for alk positive lung cancer?
-
11:49
grace targeted therapies lung cancer 2021 - online communities, education & partnership in research
-
17:58
grace targeted therapies lung cancer 2021 - kras directed therapies: a new horizon
-
14:57
grace targeted therapies lung cancer 2021 - standards & novel therapies sensitizing mutations, pt 1
-
7:27
intro and cancer 101 - grace targeted therapies in lung cancer patient forum 2021
-
7:49
alk nsclc treatment options - 2022 program: targeted therapies forum